Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours

Cancer Biology and Therapy

Volumn 9, Issue 8, 2010, Pages 585-589

  Mato, Anthony R ^c   Luger, Selina M ^a   Heitjan, Daniel F ^a   Mikkelsen, Mark E ^a   Olson, Erin ^a   Ujjani, Chaitra ^a   Jacobs, Samantha ^a   Miltiades, Andrea N ^a   Shah, Payal ^a   Schuster, Stephen J ^a   Carroll, Martin ^a   Chauffe, Ann Duskin ^b   Fuchs, Barry D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Febrile neutropenia; Hematologic malignancies; Lactate; Lactic acidosis; Sepsis; Septic shock; Severe sepsis; Systemic inflammatory response syndrome

Indexed keywords

LACTIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY INTERVENTION; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LACTATE BLOOD LEVEL; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; SEPTIC SHOCK; TACHYPNEA; UNIVARIATE ANALYSIS; VITAL SIGN;

EID: 77953709282     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.8.11270     Document Type: Article

References (41)

1. Hathorn JW, Lyke K. Empirical treatment of febrile neutropenia: evolution of current therapeutic approaches. Clin Infect Dis 1997; 24:256-65.
2. Viscoli C, Varnier O, Machetti M, Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology and risk stratification. Clin Infect Dis 2005; 40:240-5.
3. Schulman AM, Claridge JA, Carr G, Diesen DL, Young JS, Schulman AM, et al. Predictors of patients who will develop prolonged occult hypoperfusion following blunt trauma. Journal of Trauma-Injury Infection & Critical Care 2004; 57:795-800. (Pubitemid 39431199)
4. Manikis P, Jankowski S, Zhang H, Kahn RJ, Vincent JL. Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med 1995; 13:619-22.
5. Vincent JL, Dufaye P, Berre J, Leeman M, Degaute JP, Kahn RJ. Serial lactate determinations during circulatory shock. Crit Care Med 1983; 11:449-51. (Pubitemid 13057566)
6. Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J. Lactate clearance and survival following injury. Journal of Trauma-Injury Infection & Critical Care 1993; 35:584-8.
7. Aduen J, Bernstein WK, Khastgir T, Miller J, Kerzner R, Bhatiani A, et al. The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. JAMA 1994; 272:1678-85.
8. Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 1996; 171:221-6.
9. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32:1637-42.
10. Shapiro NI, Howell MD, Talmor D, Nathanson LA, Lisbon A, Wolfe RE, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med 2005; 45:524-8.
11. Trzeciak S, Dellinger RP, Chansky ME, Arnold RC, Schorr C, Milcarek B, et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 2007; 33:970-7.
12. Howell MD, Donnino M, Clardy P, Talmor D, Shapiro NI, Howell MD, et al. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med 2007; 33:1892-9.
13. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009; 37:1670-7.
14. Smith JWAR. Determination of Lactic Acid in Human Serum by Ion Exchange Chromatography Internal Eastman Kodak Company Report 1982.
15. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-51.
16. Lubin JH, Gail MH. Biased selection of controls for case-control analyses of cohort studies. Biometrics 1984; 40:63-75.
17. Flanders WD, Louv WC. The exposure odds ratio in nested case-control studies with competing risks. Am J Epidemiol 1986; 124:684-92.
18. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6.
19. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536-55.
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
21. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993; 138:923-36.
22. Babmer D. The area above the ordinal dominance graph and the area below the receiver operating characteristic graph. J Math Psych 1975; 12:387-415.
23. Crowl AC, Young JS, Kahler DM, Claridge JA, Chrzanowski DS, Pomphrey M. Occult hypoperfusion is associated with increased morbidity in patients undergoing early femur fracture fixation. Journal of Trauma-Injury Infection & Critical Care 2000; 48:260-7. (Pubitemid 30112076)
24. Smith I, Kumar P, Molloy S, Rhodes A, Newman PJ, Grounds RM, et al. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med 2001; 27:74-83.
25. Meregalli A, Oliveira RP, Friedman G, Meregalli A, Oliveira RP, Friedman G. Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients. Crit Care (London, England) 2004; 8:60-5.
26. Ander DS, Jaggi M, Rivers E, Rady MY, Levine TB, Levine AB, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol 1998; 82:888-91.
27. Jansen TC, van Bommel J, Mulder PG, Rommes JH, Schieveld SJ, Bakker J, et al. The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: a pilot study. Crit Care (London, England) 2008; 12:160.
28. Ramzi J, Mohamed Z, Yosr B, Karima K, Raihane B, Lamia A, at al. Predictive factors of septic shock and mortality in neutropenic patients. Hematology 2007; 12:543-8.
29. Blow O, Magliore L, Claridge JA, Butler K, Young JS. The golden hour and the silver day: detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma. Journal of Trauma-Injury Infection & Critical Care 1999; 47:964-9.
30. Svaldi M, Hirber J, Lanthaler AI, Mayr O, Faes S, Peer E, et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001; 115:53-7.
31. Wo CC, Shoemaker WC, Appel PL, Bishop MH, Kram HB, Hardin E. Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness. Crit Care Med 1993; 21:218-23.
32. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early Goal-Directed Therapy Collaborative G. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-77.
33. Donnino MW, Nguyen B, Jacobsen G, Tomlanovich M, Rivers E. Cryptic Septic Shock: A Sub-analysis of Early, Goal-Directed Therapy. Chest 2003; 124:90.
34. Caspar CB, Oelz O. Lactic acidosis in malignant lymphoma. Am J Med 1991; 91:197-8.
35. Nadiminti Y, Wang JC, Chou SY, Pineles E, Tobin MS. Lactic acidosis associated with Hodgkin's disease: response to chemotherapy. N Engl J Med 1980; 303:15-7. (Pubitemid 10073392)
36. Sillos EM, Shenep JL, Burghen GA, Pui CH, Behm FG, Sandlund JT. Lactic acidosis: a metabolic complication of hematologic malignancies: case report and review of the literature. Cancer 2001; 92:2237-46.
37. Archer S, Bache-Wiig B. Lactic acidosis B associated with solid tumors. Minnesota Medicine 1986; 69:511-4.
38. Ustun C, Fall P, Szerlip HM, Jillella A, Hendricks L, Burgess R, et al. Multiple myeloma associated with lactic acidosis. Leuk Lymphoma 2002; 43:2395-7.
39. Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol 2000; 27:322-34.
40. Block JB. Lactic acidosis in malignancy and observations on its possible pathogenesis. Ann N Y Acad Sci 1974; 230:94-102.
41. VanderMolen LA, Swain S, Longo DL. Lactic acidosis in lymphoma: prompt resolution of acidosis with therapy directed at the lymphoma. J Natl Cancer Inst 1988; 80:1077-8.